An Introduction to Cardiovascular Disease
Cardiovascular diseases (CVDs) are the number one cause of death globally, taking an estimated 17.9 million lives each year. CVDs describe a number of conditions affecting the heart and circulation, including coronary heart disease, angina, congenital heart disease, hypertension and stroke. The huge and ever-increasing burden of CVDs on individuals and healthcare systems shows the urgent ongoing need for treatments and preventive measures.
Browse the content below where leading experts discuss the latest data in video interviews and short articles from our conference hub, and browse the selection of peer-reviewed articles from our journal portfolio. If you are looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.
Our supporting partners do not constitute an endorsement of the content on this page.
Cardiovascular Disease Content
ST-elevation Myocardial Infarction and Multivessel Coronary Artery Disease – A Critical Review of Current Practice, Evidence and Meta-analyses
Heart International. 2020;14(2):80-5 DOI: https://doi.org/10.17925/HI.2020.14.2.80
Reperfusion of infarct-related artery (IRA) in acute ST-elevation myocardial infarction (STEMI) is the procedure with the most clinical benefit in interventional cardiology. However, in around 50% of patients presenting with STEMI, other significant lesions are present, a finding which is associated to a worse prognosis.1,2 Most physicians performing primary percutaneous coronary intervention (PCI) have been trained […]
Current and future management of hyperlipidaemia and atherosclerosis: From statins to combination therapy
Watch an expert panel discuss cholesterol-lowering regimens in the management of hyperlipidaemia and atherosclerosis.
- Recall the current standard of care for cholesterol-lowering therapy and the potential limitations of statin monotherapy
- Discuss the clinical considerations which guide the choice of second-line or add-on therapy when statin monotherapy is ineffective or not tolerated
- Summarize the most recent data on the effect of dual lipid-lowering therapy on hyperlipidaemia and the risk for atherosclerosis
The Role of Transoesophageal Echocardiography in Surgical Removal of a Mediastinal Tumour
Heart International. 2020;14(2):118-20 DOI: https://doi.org/10.17925/HI.2020.14.2.118
Perioperative management of a mediastinal tumour is an anaesthetic challenge. Echocardiography is not considered as a primary diagnostic modality in the evaluation of a mediastinal mass; however, it can provide valuable information in patients with clinical and diagnostic evidence of cardiac compression or encroachment. Judicious interpretation of perioperative transthoracic or transoesophageal echocardiographic images may be […]
Gustavo Samaja, ESC 2020 – Myocardial Infarction with no Obstructive Coronary Arteries
We spoke to Dr Gustavo Samaja (Policlinico Bancario, Buenos Aires, Argentina) about myocardial infarction with no obstructive coronary arteries (MINOCA), and especially its prevalence and importance during the COVID-19 pandemic. Questions Could you give us a brief overview of myocardial infarction with no obstructive coronary arteries (MINOCA)? (0:33) How prevalent is MINOCA and what […]
David Playford, ESC 2020 – Diastolic Function and Mortality Part 1
We spoke to Professor David Playford (University of Notre Dame, Perth, Australia) regarding diastolic function and dysfunction, the National Echo Database Australia (NEDA), and then focused on his recent study on diastolic function and mortality. Questions What are the prognostic implications of diastolic dysfunction? (0:07) How do you classify patients by diastolic function? (1:18) […]
David Playford, ESC 2020 – Diastolic Function and Mortality Part 2
We spoke to Professor David Playford (University of Notre Dame, Perth, Australia) regarding diastolic function and dysfunction, the National Echo Database Australia (NEDA), and then focused on his recent study on diastolic function and mortality. Questions What were the aims and design of your recent study on diastolic function and mortality? (0:07) What were the […]
Kazem Rahimi, ESC 2020 – Blood Pressure Lowering for Prevention of Cardiovascular Events
We spoke to Dr Kazem Rahimi (Oxford University, Oxford, UK) about the Blood Pressure Lowering Treatment Trialists Collaboration (BPLTTC) and their recent study examining blood pressure lowering to prevent cardiovascular events. Questions Could you tell us a little about the Blood Pressure Lowering Treatment Trialists Collaboration (BPLTTC) and its objectives? (0.13) Could you give us […]
Uwe Zeymer, ESC 2020 – the ACS STEMI Registry Study
We caught up with Professor Uwe Zeymer (Klinikum Ludwigshafen, Ludwigshafen, Germany) on the current treatment limitations for ST elevation myocardial infarction and the acute coronary syndrome (ACS) STEMI registry study. Questions What are the limitations of current treatment paradigms for ST elevation myocardial infarction (STEMI)?(0.06) What are the objectives of the ACS STEMI registry study? […]
Thomas Lüscher, ESC 2020 – Gut Microbiota and Cardiovascular Disease
We caught up with Prof Thomas Lüscher (Royal Brompton and Harefield Hospital and Imperial College, London, UK) on the association between gut microbiota, the gut microbiome and cardiovascular disease. Questions What is known about the association between gut microbiome changes and cardiovascular disease? (0.38) Which gut microbiota–dependent metabolites are involved in the pathogenesis of cardiovascular […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!